
HongShan
Description
HongShan, formerly known as Sequoia China, is a preeminent venture capital firm based in Beijing, China, that officially rebranded in June 2023. This strategic separation from the global Sequoia network marked a new chapter for the firm, allowing it to operate independently while maintaining its deep roots and extensive network within the Chinese market. Building on a legacy of identifying and nurturing groundbreaking companies, HongShan continues to be a pivotal player in China's innovation ecosystem, deploying capital across various stages from seed to late-stage and growth investments.
The firm's investment strategy is comprehensive, targeting a broad spectrum of high-growth sectors beyond just fintech, including technology, consumer, healthcare, and industrial technology. HongShan leverages its profound local market understanding and operational expertise to support its portfolio companies, helping them scale rapidly and achieve market leadership. Its approach is characterized by a long-term perspective, often providing not just capital but also strategic guidance, talent acquisition support, and access to a vast network of industry leaders and partners.
With an impressive track record, HongShan has been instrumental in backing some of China's most successful enterprises. In 2022, the firm reportedly raised approximately $9 billion across four new funds, underscoring its significant financial capacity and investor confidence. Since its inception in 2005, the firm has invested in over 1,200 companies, many of which have gone on to achieve significant valuations, including numerous IPOs and successful exits. This extensive portfolio and consistent ability to identify future market leaders solidify HongShan's position as a dominant force in the Asian venture capital landscape.
Investor Profile
HongShan has backed more than 354 startups, with 36 new investments in the last 12 months alone. The firm has led 136 rounds, about 38% of its total and boasts 108 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Series C rounds (top funding stages).
- Majority of deals are located in China, United States, Singapore.
- Strong thematic focus on Biotechnology, Artificial Intelligence (AI), E-Commerce.
- Led 15 rounds in the past year.
- Typical check size: $1M – $150M.
Stage Focus
- Series B (25%)
- Series A (22%)
- Series C (16%)
- Seed (10%)
- Series D (9%)
- Series Unknown (5%)
- Series E (4%)
- Series F (3%)
- Private Equity (2%)
- Angel (2%)
Country Focus
- China (66%)
- United States (10%)
- Singapore (6%)
- Hong Kong (4%)
- Australia (4%)
- South Korea (2%)
- France (1%)
- Nigeria (1%)
- Japan (1%)
- Switzerland (1%)
Industry Focus
- Biotechnology
- Artificial Intelligence (Ai)
- E-commerce
- Software
- Health Care
- Internet
- Information Technology
- Financial Services
- Medical
- Apps
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.